Skip to nav Skip to content
Facebook Twitter LinkedIn Email

IDSA Supports Authorization of Bivalent COVID-19 Boosters

The Infectious Diseases Society of America supports decisions by the Food and Drug Administration and the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices to authorize and recommend boosters meant to curb cases of more highly infectious strains of COVID-19.

Evidence shows that these bivalent vaccines — created specifically for the highly transmissible Omicron variant — provide needed broader and more durable protections.

IDSA supports plans to make the boosters widely available, including increasing access in communities that are at high risk of infection and where COVID-19 has had a disproportionate impact.

COVID-19 is not over. Nearly 400 people die from COVID every day, and almost 5,000 people are currently hospitalized with COVID. Vaccines are the best way to prevent serious infection, hospitalization and death. Infectious diseases experts urge everyone who is eligible to get boosters.

Daniel P. McQuillen, MD, FIDSA – President, Infectious Diseases Society of America

About IDSA
The Infectious Diseases Society of America is a community of more than 12,000 physicians, scientists and public health experts who specialize in infectious diseases. Its purpose is to improve the health of individuals, communities and society by promoting excellence in patient care, education, research, public health and prevention relating to infectious diseases. Learn more at

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.